摘要
Precision cardiology aims to implement personalized health care and precise medical decisions based on the specific characteristics of individuals.Metabolic remodeling plays a causal role in the pathogenesis of heart failure(HF).Changes in metabolic pathways such as substrate preference,high-energy phosphate metabolism and amino acid metabolism,are involved in pathological structural remodeling and functional impairment.These metabolic alterations are usually not restricted in the cardiac tissue,but also manifest in circulation.In clinical practice,blood sample is routinely used for HF screening.Metabolomics is an emerging omics technology that provides an efficient way to acquire dynamic metabolic profiles in circulation.An increasing number of metabolic biomarkers have been implicated in disease progression,making it possible to fight HF in a more effective and precise way.This review summarizes the modern analytical techniques in metabolomics as well as emerging circulating metabolites during the pathogenesis of HF,aiming to provide new insights into the prevention,diagnosis and treatment of HF in the era of precision medicine.
基金
supported in part by grants from the National Natural Science Foundation of China(Grant No.81970715)
the Key Research and Development Program of Sichuan Province(Grant No.2022YFS0132)
the Innovation Spark Project of Sichuan University(Grant No.2018SCUH0065).
